Write to us
outreach@ceaiglobal.com

Study: AI might prove helpful against asbestos-linked cancer

"A new international genomics research led by the University of Leicester used artificial intelligence (AI) to study an aggressive form of cancer, which could be helpful in improving patient outcomes. ...New research undertaken by the Leicester Mesothelioma Research Programme has now revealed, using AI analysis of DNA-sequenced mesotheliomas, that they evolve along similar or repeated paths between individuals. These paths predict the aggressiveness and possible therapy of this otherwise incurable cancer."

A new international genomics research led by the University of Leicester used artificial intelligence (AI) to study an aggressive form of cancer, which could be helpful in improving patient outcomes.

Mesothelioma is caused by breathing asbestos particles and most commonly occurs in the linings of the lungs or abdomen. Currently, only seven per cent of people survive five years after diagnosis, with a prognosis averaging 12 to 18 months.

New research undertaken by the Leicester Mesothelioma Research Programme has now revealed, using AI analysis of DNA-sequenced mesotheliomas, that they evolve along similar or repeated paths between individuals. These paths predict the aggressiveness and possible therapy of this otherwise incurable cancer.

Professor Dean Fennell, Chair of Thoracic Medical Oncology at the University of Leicester and Director of the Leicester Mesothelioma Research Programme, said: “It has long been appreciated that asbestos causes mesothelioma, however, how this occurs remains a mystery.”

“Using AI to interrogate genomic ‘big data’, this initial work shows us that mesotheliomas follow ordered paths of mutations during development and that these so-called trajectories predict not only how long a patient may survive, but also how to better treat cancer – something Leicester aims to lead on internationally through clinical trial initiatives.”

While the use of asbestos is now outlawed – and stringent regulations in place on its removal – each year around 25 people are diagnosed with mesothelioma in Leicestershire and 190 are diagnosed in the East Midlands. Cases of mesothelioma in the UK have increased by 61 per cent since the early 1990s.

Until very recently, chemotherapy was the only licenced choice for patients with mesothelioma. However, treatment options start to become limited once people stop responding to their treatment.

Professor Fennell in collaboration with the University of Southampton recently made a major breakthrough in treating the disease by demonstrating that the use of an immunotherapy drug called nivolumab increased survival and stabilised the disease for patients. This was the first-ever trial to demonstrate improved survival in patients with relapsed mesothelioma.

Source: Asian News International

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on telegram
Telegram
Share on whatsapp
WhatsApp
Share on email
Email

AI Blog – Latest news on Artificial Intelligence and its applications on the globe. 

Browse more

Related Posts

Mengatasi Keperluan Mendalam untuk Pembiayaan Sekolah: Pelancaran Projek SEMADI

“Sekolah-seolkah, terutama di kawasan luar bandar, menghadapi cabaran besar dalam mendapatkan pembiayaan yang mencukupi untuk kelangsungan hidup dan pembangunan kapasiti. Kajian terkini menunjukkan bahawa hampir 40% sekolah di kawasan ini kekurangan sumber asas, yang membawa kepada hasil pendidikan yang rendah dan peningkatan kadar putus sekolah. Dengan sistem pendidikan yang tertekan, adalah penting untuk menangani kekurangan pembiayaan ini bagi memastikan masa depan yang lestari untuk anak-anak kita.”

Read More »

Addressing the Urgent Need for School Funding: Launch of Projek SEMADI

“TREO and AIV50 are pleased to announce the signing of a Memorandum of Understanding (MOU) to collaborate on a series of strategic initiatives aimed at fostering the growth of high-potential AI ventures. This partnership underscores both companies’ commitment to leveraging advanced business combination strategies and innovative market engagement practices.

Read More »